Connect your AI

Esperion Therapeutics ESPR Inventories

Inventories at other companies

AmgenAMGN

$6.19B-8.1%

Regeneron PharmaceuticalsREGN

$3.1B-2.8%

Lexicon PharmaceuticalsLXRX

$276K+37.3%

Zevra Therapeutics, Inc.ZVRA

$0-100%

Eton Pharmaceuticals, Inc.ETON

$14.47M+6.2%

BridgeBio PharmaBBIO

$32.98M+734%

Other financials

Income statement

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Esperion Therapeutics's inventories?: Esperion Therapeutics (ESPR) reported inventories of $104.21M in Q1 2026.
How has Esperion Therapeutics's inventories changed year-over-year?: Esperion Therapeutics's inventories increased by 4.9% year-over-year, from $99.32M to $104.21M.
What is the long-term trend for Esperion Therapeutics's inventories?: Over 5 years (2020 to 2025), Esperion Therapeutics's inventories has grown at a 45.5% compound annual growth rate (CAGR), from $16.14M to $105.12M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.